[go: up one dir, main page]

GR3015939T3 - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
GR3015939T3
GR3015939T3 GR950400874T GR950400874T GR3015939T3 GR 3015939 T3 GR3015939 T3 GR 3015939T3 GR 950400874 T GR950400874 T GR 950400874T GR 950400874 T GR950400874 T GR 950400874T GR 3015939 T3 GR3015939 T3 GR 3015939T3
Authority
GR
Greece
Prior art keywords
pharmaceutical composition
core
prostaglandin
coating
nsaid
Prior art date
Application number
GR950400874T
Other languages
English (en)
Inventor
Rene Antoine Gimet
Jean-Charles Jinot
Christian Magnet
Isabelle Maroteaux
Francoise M Nevoux
Roger Scoyer
Barbara J Struthers
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24063571&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3015939(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Searle & Co filed Critical Searle & Co
Publication of GR3015939T3 publication Critical patent/GR3015939T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GR950400874T 1990-05-03 1995-04-27 Pharmaceutical composition. GR3015939T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51835390A 1990-05-03 1990-05-03
PCT/US1991/002980 WO1991016895A1 (en) 1990-05-03 1991-05-01 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GR3015939T3 true GR3015939T3 (en) 1995-07-31

Family

ID=24063571

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950400874T GR3015939T3 (en) 1990-05-03 1995-04-27 Pharmaceutical composition.

Country Status (15)

Country Link
US (2) US5601843A (el)
EP (1) EP0527887B1 (el)
AT (1) ATE121625T1 (el)
AU (1) AU7876491A (el)
CA (1) CA2082944C (el)
DE (1) DE69109286T2 (el)
DK (1) DK0527887T3 (el)
ES (1) ES2071312T3 (el)
GR (1) GR3015939T3 (el)
IE (1) IE68596B1 (el)
IL (1) IL98033A (el)
NZ (1) NZ238024A (el)
PT (1) PT97562B (el)
WO (1) WO1991016895A1 (el)
ZA (1) ZA913353B (el)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7876491A (en) * 1990-05-03 1991-11-27 G.D. Searle & Co. Pharmaceutical composition
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5324746A (en) * 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
DE4341442C2 (de) * 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
EP0853481A1 (en) * 1995-09-27 1998-07-22 Merck Frosst Canada Inc. Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
EP1005336A4 (en) 1997-07-09 2001-01-17 Androsolutions Inc IMPROVED METHODS AND COMPOSITIONS FOR TREATING MALE ERECTIONAL DISORDERS
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
GB9814215D0 (en) * 1998-07-01 1998-09-02 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6319519B2 (en) 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
US6387410B1 (en) 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6514525B2 (en) 1998-09-10 2003-02-04 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
GB9819685D0 (en) * 1998-09-10 1998-11-04 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
SE9803761D0 (sv) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
US7429407B2 (en) * 1998-12-30 2008-09-30 Aeromatic Fielder Ag Process for coating small bodies, including tablets
CA2259727A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
US6183779B1 (en) 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
CA2277407A1 (en) * 1999-07-14 2001-01-14 Bernard Charles Sherman Pharmaceutical tablet comprising an nsaid and misoprostol
EP1216030A1 (en) * 1999-10-01 2002-06-26 Norton Healthcare Limited Anti-inflammatory pharmaceutical formulations
US6761895B2 (en) * 2000-04-17 2004-07-13 Yamanouchi Pharmaceutical Co., Ltd. Drug delivery system for averting pharmacokinetic drug interaction and method thereof
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
CA2477088A1 (en) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
WO2004064815A1 (en) * 2003-01-21 2004-08-05 Smartrix Technologies Inc. Oral dosage formulation
EP1462098B1 (en) * 2003-03-03 2007-07-04 SPRL Franpharma Stabilised pharmaceutical composition comprising a non-steroidal anti-inflammatory agent and a prostaglandin
WO2004091579A1 (en) * 2003-04-16 2004-10-28 Pharmacia Corporation Stabilized prostaglandin formulation
US7241746B2 (en) 2003-08-06 2007-07-10 Regena Therapeutics, Lc Method and composition for treating periodontal disease
US20050163847A1 (en) * 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067451B2 (en) 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
US20150224056A1 (en) * 2006-07-18 2015-08-13 Horizon Pharma Usa, Inc. Pharmaceutical compositions of ibuprofen and famotidine
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
WO2008027963A2 (en) * 2006-08-31 2008-03-06 Horizon Therapeutics, Inc. Nsaid dose unit formulations with h2-receptor antagonists and methods of use
WO2008146178A2 (en) 2007-05-30 2008-12-04 Wockhardt Research Centre A novel tablet dosage form
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
EP2210595A1 (en) 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Active coating of pharmaceutical dosage forms
CN102638978A (zh) * 2009-06-25 2012-08-15 波曾公司 用于治疗需要阿司匹林治疗之患者的方法
JP2012531409A (ja) 2009-06-25 2012-12-10 アストラゼネカ・アクチエボラーグ Nsaid関連潰瘍を発症するリスクがある患者の処置方法
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
AU2017249011A1 (en) * 2016-04-11 2018-10-25 University Of Utah Research Foundation Methods for treating NSAID-induced cardiovascular, cerebrovascular, or renovascular adverse events

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135881B (en) * 1983-03-02 1986-09-17 Erba Farmitalia Pharmaceutical compositions for inhibiting or reducing gastrointestinal side effects of non-steroidal anti-inflammatory drugs
IT1190400B (it) * 1985-10-04 1988-02-16 Istituto Biochimico Italiano Derivati dell'acido 19,20-bis,nor-prostanoico ad attivita' antiulcera e anoressivca,procedimento per la loro preparazione e composizioni farmaceutiche
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method
US4975283A (en) * 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
DE3603576A1 (de) * 1986-02-06 1987-08-13 Code Kaffee Handel Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz
JPH01139528A (ja) * 1987-11-24 1989-06-01 Showa Denko Kk 抗潰瘍剤
AU7876491A (en) * 1990-05-03 1991-11-27 G.D. Searle & Co. Pharmaceutical composition

Also Published As

Publication number Publication date
DE69109286D1 (de) 1995-06-01
DE69109286T2 (de) 1995-09-28
NZ238024A (en) 1993-08-26
US5601843A (en) 1997-02-11
ATE121625T1 (de) 1995-05-15
WO1991016895A1 (en) 1991-11-14
CA2082944C (en) 1998-11-24
IL98033A0 (en) 1992-06-21
DK0527887T3 (da) 1995-07-03
ZA913353B (en) 1993-04-28
PT97562A (pt) 1992-02-28
US5698225A (en) 1997-12-16
AU7876491A (en) 1991-11-27
CA2082944A1 (en) 1991-11-04
IE911486A1 (en) 1991-11-06
EP0527887A1 (en) 1993-02-24
ES2071312T3 (es) 1995-06-16
EP0527887B1 (en) 1995-04-26
IE68596B1 (en) 1996-06-26
IL98033A (en) 1995-07-31
PT97562B (pt) 1998-08-31

Similar Documents

Publication Publication Date Title
GR3015939T3 (en) Pharmaceutical composition.
NO923947D0 (no) Smaksmaskering av ibuprofen ved fluidlagbelegning
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
MX9605646A (es) Preparacion de nifedipino de liberacion prolongada.
USD264738S (en) Coil exerciser
AR244918A1 (es) Un amplificador optico del tipo de fibra activa
NO911934D0 (no) Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
DK0643705T3 (da) Fremgangsmåde til fremstilling af N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecan- og N-beta-hydroxyal
FR2670865B1 (fr) Lampe pour salle d'operation.
HU9500818D0 (en) Retarde compositions containing alfuzonin-hydrochloride
BE890847A (fr) Electro-aimant, notamment pour l'actionnement d'une valve
JO1704B1 (en) New potent compounds
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
MY131277A (en) Process for chiral thiazolidine-2,4-dione hypoglycemics and intermediates
AU3234789A (en) 2-(2-(substituted)pyrid-3-yl oxy)-4,6-dimethoxy-pyrimidines
ES8301928A1 (es) Un procedimiento para preparar 4-(2-4-dicloro-3-metilbenzoil)-1,3-dimetil-5-fenaciloxipirazol).
DE69200867D1 (de) Betätigungseinrichtung eines Getriebes.
USD268652S (en) Medal
AU4539396A (en) Fungicidal aza-heterocycloalkenes
MY104318A (en) Novel thiopen compounds and their preparation
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
AU9178198A (en) Diamond core with a diamond coating
FR2690766B1 (fr) Interface programmable notamment pour la commande d'installations domestiques.
FR2664353B1 (fr) Clapet pour pulverisateur.